These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 19395948

  • 1. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD, D153-P504 LAIV Study Group.
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL, Toback SL, Yi T, Ambrose CS.
    Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.
    Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024
    [Abstract] [Full Text] [Related]

  • 4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 11; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 11; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 6. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
    Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD, CAIV-T Pediatric Day Care Clinical Trial Network.
    Pediatrics; 2006 Dec 11; 118(6):2298-312. PubMed ID: 17142512
    [Abstract] [Full Text] [Related]

  • 7. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct 11; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 11; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 9. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM, Yi T, Ambrose CS.
    Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.
    N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647
    [Abstract] [Full Text] [Related]

  • 11. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF, Brooks WA, Goswami D, Lagos R, Borja-Tabora C, Lanata CF, Londoño JA, Lum LC, Rappaport R, Razmpour A, Walker RE, Gruber WC, Forrest BD.
    Vaccine; 2009 Sep 04; 27(40):5472-9. PubMed ID: 19616493
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS, Wu X, Knuf M, Wutzler P.
    Vaccine; 2012 Jan 20; 30(5):886-92. PubMed ID: 22155144
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.
    Vaccine; 2011 Nov 21; 29(50):9391-7. PubMed ID: 21983154
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB, Ambrose CS, Yi T.
    Vaccine; 2008 Sep 12; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [Abstract] [Full Text] [Related]

  • 15. Duration of protection provided by live attenuated influenza vaccine in children.
    Ambrose CS, Yi T, Walker RE, Connor EM.
    Pediatr Infect Dis J; 2008 Aug 12; 27(8):744-8. PubMed ID: 18600188
    [Abstract] [Full Text] [Related]

  • 16. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.
    Expert Rev Vaccines; 2004 Dec 12; 3(6):643-54. PubMed ID: 15606348
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
    Block SL, Falloon J, Hirschfield JA, Krilov LR, Dubovsky F, Yi T, Belshe RB.
    Pediatr Infect Dis J; 2012 Jul 12; 31(7):745-51. PubMed ID: 22466322
    [Abstract] [Full Text] [Related]

  • 18. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X.
    Vaccine; 2010 Feb 25; 28(9):2149-56. PubMed ID: 20003926
    [Abstract] [Full Text] [Related]

  • 20. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T, Karvonen A, Smith HM, Dunning A, Razmpour A, Saville MK, Gruber WC, Forrest BD.
    Pediatrics; 2008 Mar 25; 121(3):e568-73. PubMed ID: 18299305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.